Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 2
2015 3
2017 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.
Ruel TD, Acosta EP, Liu JP, Gray KP, George K, Montañez N, Popson S, Buchanan AM, Bartlett M, Dayton D, Anthony P, Brothers C, Vavro C, Singh R, Koech L, Vhembo T, Mmbaga BT, Pinto JA, Dobbels EFM, Archary M, Chokephaibulkit K, Ounchanum P, Deville JG, Hazra R, Townley E, Wiznia A; IMPAACT P1093 team. Ruel TD, et al. Lancet HIV. 2022 May;9(5):e332-e340. doi: 10.1016/S2352-3018(22)00044-3. Lancet HIV. 2022. PMID: 35489377 Free PMC article. Clinical Trial.
Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American Children.
Paganella MP, Cohen RA, Harris DR, de Souza Kuchenbecker R, Sperhacke RD, Kato SK, Oliveira da Silva CL, Sturzbecher FT, Oliveira RH, Pavía-Ruz N, Hazra R; NISDI PLACES Protocol. Paganella MP, et al. Among authors: sturzbecher ft. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):e1-e8. doi: 10.1097/QAI.0000000000001163. J Acquir Immune Defic Syndr. 2017. PMID: 27570910 Free PMC article.
Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean.
Succi RC, Krauss MR, Harris DR, Machado DM, de Moraes-Pinto MI, Mussi-Pinhata MM, Ruz NP, Pierre RB, Kolevic L, Joao E, Foradori I, Hazra R, Siberry GK; NISDI Pediatric Study Group 2012. Succi RC, et al. Pediatr Infect Dis J. 2013 Aug;32(8):845-50. doi: 10.1097/INF.0b013e31828bbe68. Pediatr Infect Dis J. 2013. PMID: 23860480 Free PMC article.
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group; Tuberculosis Trials Consortium. Villarino ME, et al. JAMA Pediatr. 2015 Mar;169(3):247-55. doi: 10.1001/jamapediatrics.2014.3158. JAMA Pediatr. 2015. PMID: 25580725 Free PMC article. Clinical Trial.
Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America.
Duarte HA, Harris DR, Tassiopoulos K, Leister E, Negrini SF, Ferreira FF, Cruz ML, Pinto J, Allison S, Hazra R; NISDI PLACES Study Group. Duarte HA, et al. Braz J Infect Dis. 2015 May-Jun;19(3):263-71. doi: 10.1016/j.bjid.2015.01.004. Epub 2015 Mar 3. Braz J Infect Dis. 2015. PMID: 25743569 Free PMC article.
Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy.
Siberry GK, Harris DR, Oliveira RH, Krauss MR, Hofer CB, Tiraboschi AA, Marques H, Succi RC, Abreu T, Della Negra M, Mofenson LM, Hazra R; NISDI PLACES Protocol. Siberry GK, et al. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):214-8. doi: 10.1097/QAI.0b013e31824e4da6. J Acquir Immune Defic Syndr. 2012. PMID: 22343177 Free PMC article.